Deadline: 11 October 2017
Applications are open for “Biomedical Catalyst 2017” round 3 from micro, small or medium-size UK companies who can apply for share of £10 million to work alone or with others on solving healthcare challenges.
The aim of this competition is to support the development of technologies and processes including:
- disease prevention and proactive management of health and chronic conditions
- earlier and better detection and diagnosis of disease, leading to better patient outcomes
- tailored treatments that either change the underlying disease or offer potential cures
The biomedical catalyst has 4 types of funding award designed to support small to medium enterprises (SMEs) that are developing a product or process. It helps them progress from initial concept through to late-stage development.
Funding Information
Total project costs can range between £250,000 and £4 million.
Eligibility Criteria
- Applicants must:
- be a UK-based SME to lead the project
- work on own or with other UK SMEs or research organisations. If project is academic-led, applicant should apply to the Medical Research Council instead
- carry out project work in the UK
- be ready to start project by 1 June 2018 and finish by 1 June 2021
- If applicants are a business, they can:
- take part in no more than 3 applications in this competition round. Applicants may only be the lead partner in one application
- apply only twice with the same project to any Innovate UK competition.
- The competition will support projects from any sector or discipline, including (but not limited to):
- stratified healthcare (both therapy and diagnostic components)
- regenerative medicine
- diagnostics
- enabling medical technologies and devices
How to Apply
Applications must be submitted via given website.
Eligible Country: United Kingdom
For more information, please visit Biomedical catalyst 2017.
